Cezar, Esmael .

HRN: 22-12-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
AMPICILLIN 500MG (VIAL)
10/29/2022
11/05/2022
IVTT
325mg
Q12
Pcap
Waiting Final Action 
10/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/29/2022
11/05/2022
IVTT
135mg
Q24
Pcap
Waiting Final Action 
10/29/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/29/2022
11/05/2022
IVTT
280mg
Q6h
PCAP C
Waiting Final Action 
11/01/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
11/01/2022
11/07/2022
PO
2ml
BID
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: